Guillain–Barré syndrome in Colombia: where do we stand now?

Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) inf...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2017
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/24280
Acceso en línea:
https://doi.org/10.1007/s12026-016-8816-8
https://repository.urosario.edu.co/handle/10336/24280
Palabra clave:
Corticosteroid
Corticotropin
Immunoglobulin
Prednisone
Acute inflammatory demyelinating polyneuropathy
Acute motor axonal neuropathy
Article
Autoimmune disease
Colombia
Deep vein thrombosis
Drug megadose
Dysautonomia
Electromyography
Gastrointestinal infection
Graves disease
Guillain barre syndrome
Human
Incidence
Intervention study
Literature
Lung embolism
Meta analysis
Muscle strength
Muscle weakness
Nerve conduction
Outcome assessment
Peripheral nervous system
Plasmapheresis
Priority journal
Systematic review
Urinary tract infection
Vaccination
Ventilator associated pneumonia
Zika virus
Colombia
Guillain barre syndrome
Immunology
Pathophysiology
Colombia
Guillain-barre syndrome
Humans
Anti-gangliosides antibodies
Guillain–barré syndrome
Latin america
Zika virus
Rights
License
Abierto (Texto Completo)
id EDOCUR2_020de57b19f13867f7f893f5610b4b8b
oai_identifier_str oai:repository.urosario.edu.co:10336/24280
network_acronym_str EDOCUR2
network_name_str Repositorio EdocUR - U. Rosario
repository_id_str
spelling 06ca03f0-d941-410a-8ff1-339af01ee4d3f93a35c6-cfd6-477e-af82-501c638fca6d00775a99-006f-4214-aeab-93e462d739348002bf3a-1fbf-4a74-9722-32633fa8878d194747786002020-05-26T00:11:05Z2020-05-26T00:11:05Z2017Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York.application/pdfhttps://doi.org/10.1007/s12026-016-8816-80257277Xhttps://repository.urosario.edu.co/handle/10336/24280engHumana Press Inc.81No. 172Immunologic ResearchVol. 65Immunologic Research, ISSN:0257277X, Vol.65, No.1 (2017); pp. 72-81https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978870287&doi=10.1007%2fs12026-016-8816-8&partnerID=40&md5=5e3da82270f488d17b93e77e82f2d49dAbierto (Texto Completo)http://purl.org/coar/access_right/c_abf2instname:Universidad del Rosarioreponame:Repositorio Institucional EdocURCorticosteroidCorticotropinImmunoglobulinPrednisoneAcute inflammatory demyelinating polyneuropathyAcute motor axonal neuropathyArticleAutoimmune diseaseColombiaDeep vein thrombosisDrug megadoseDysautonomiaElectromyographyGastrointestinal infectionGraves diseaseGuillain barre syndromeHumanIncidenceIntervention studyLiteratureLung embolismMeta analysisMuscle strengthMuscle weaknessNerve conductionOutcome assessmentPeripheral nervous systemPlasmapheresisPriority journalSystematic reviewUrinary tract infectionVaccinationVentilator associated pneumoniaZika virusColombiaGuillain barre syndromeImmunologyPathophysiologyColombiaGuillain-barre syndromeHumansAnti-gangliosides antibodiesGuillain–barré syndromeLatin americaZika virusGuillain–Barré syndrome in Colombia: where do we stand now?articleArtículohttp://purl.org/coar/version/c_970fb48d4fbd8a85http://purl.org/coar/resource_type/c_6501Mahecha, María P.Ojeda, ErnestoVega, Daniel A.Sarmiento-Monroy, Juan C.Anaya, Juan-Manuel10336/24280oai:repository.urosario.edu.co:10336/242802022-05-02 07:37:13.599361https://repository.urosario.edu.coRepositorio institucional EdocURedocur@urosario.edu.co
dc.title.spa.fl_str_mv Guillain–Barré syndrome in Colombia: where do we stand now?
title Guillain–Barré syndrome in Colombia: where do we stand now?
spellingShingle Guillain–Barré syndrome in Colombia: where do we stand now?
Corticosteroid
Corticotropin
Immunoglobulin
Prednisone
Acute inflammatory demyelinating polyneuropathy
Acute motor axonal neuropathy
Article
Autoimmune disease
Colombia
Deep vein thrombosis
Drug megadose
Dysautonomia
Electromyography
Gastrointestinal infection
Graves disease
Guillain barre syndrome
Human
Incidence
Intervention study
Literature
Lung embolism
Meta analysis
Muscle strength
Muscle weakness
Nerve conduction
Outcome assessment
Peripheral nervous system
Plasmapheresis
Priority journal
Systematic review
Urinary tract infection
Vaccination
Ventilator associated pneumonia
Zika virus
Colombia
Guillain barre syndrome
Immunology
Pathophysiology
Colombia
Guillain-barre syndrome
Humans
Anti-gangliosides antibodies
Guillain–barré syndrome
Latin america
Zika virus
title_short Guillain–Barré syndrome in Colombia: where do we stand now?
title_full Guillain–Barré syndrome in Colombia: where do we stand now?
title_fullStr Guillain–Barré syndrome in Colombia: where do we stand now?
title_full_unstemmed Guillain–Barré syndrome in Colombia: where do we stand now?
title_sort Guillain–Barré syndrome in Colombia: where do we stand now?
dc.subject.keyword.spa.fl_str_mv Corticosteroid
Corticotropin
Immunoglobulin
Prednisone
Acute inflammatory demyelinating polyneuropathy
Acute motor axonal neuropathy
Article
Autoimmune disease
Colombia
Deep vein thrombosis
Drug megadose
Dysautonomia
Electromyography
Gastrointestinal infection
Graves disease
Guillain barre syndrome
Human
Incidence
Intervention study
Literature
Lung embolism
Meta analysis
Muscle strength
Muscle weakness
Nerve conduction
Outcome assessment
Peripheral nervous system
Plasmapheresis
Priority journal
Systematic review
Urinary tract infection
Vaccination
Ventilator associated pneumonia
Zika virus
Colombia
Guillain barre syndrome
Immunology
Pathophysiology
Colombia
Guillain-barre syndrome
Humans
Anti-gangliosides antibodies
Guillain–barré syndrome
Latin america
Zika virus
topic Corticosteroid
Corticotropin
Immunoglobulin
Prednisone
Acute inflammatory demyelinating polyneuropathy
Acute motor axonal neuropathy
Article
Autoimmune disease
Colombia
Deep vein thrombosis
Drug megadose
Dysautonomia
Electromyography
Gastrointestinal infection
Graves disease
Guillain barre syndrome
Human
Incidence
Intervention study
Literature
Lung embolism
Meta analysis
Muscle strength
Muscle weakness
Nerve conduction
Outcome assessment
Peripheral nervous system
Plasmapheresis
Priority journal
Systematic review
Urinary tract infection
Vaccination
Ventilator associated pneumonia
Zika virus
Colombia
Guillain barre syndrome
Immunology
Pathophysiology
Colombia
Guillain-barre syndrome
Humans
Anti-gangliosides antibodies
Guillain–barré syndrome
Latin america
Zika virus
description Guillain–Barré syndrome (GBS) is a rapid-onset muscle weakness disease caused by the immune-mediated damage of the peripheral nervous system. Since there is an increase incidence of GBS cases in Latin America, particularly in Colombia, and most of them are currently preceded by Zika virus (ZIKV) infection, we aimed to assess the available evidence of the disease in Colombia through a systematic literature review. Out of 51 screened abstracts, only 16 corresponded to articles that met inclusion criteria, of which 15 were case reports or case series. A total of 796 cases of GBS were reported in the included articles. The majority of patients were males (66.8 %) and younger than 50 years old (94 %). An infectious disease before the onset of GBS was registered in 31 % of patients, with gastrointestinal or respiratory symptoms being the most frequently observed. In those cases in which electrodiagnostic tests were performed, the most common subphenotype was acute inflammatory demyelinating polyneuropathy (17 %). Death was reported in 15 % of patients. Data regarding GBS in Colombia is scant and heterogeneous. Taking into account the burden of the disease and the recent rise of GBS cases associated with ZIKV, a careful patient evaluation and a systematic collection of data are warranted. A form to data gathering is proposed. © 2016, Springer Science+Business Media New York.
publishDate 2017
dc.date.created.spa.fl_str_mv 2017
dc.date.accessioned.none.fl_str_mv 2020-05-26T00:11:05Z
dc.date.available.none.fl_str_mv 2020-05-26T00:11:05Z
dc.type.eng.fl_str_mv article
dc.type.coarversion.fl_str_mv http://purl.org/coar/version/c_970fb48d4fbd8a85
dc.type.coar.fl_str_mv http://purl.org/coar/resource_type/c_6501
dc.type.spa.spa.fl_str_mv Artículo
dc.identifier.doi.none.fl_str_mv https://doi.org/10.1007/s12026-016-8816-8
dc.identifier.issn.none.fl_str_mv 0257277X
dc.identifier.uri.none.fl_str_mv https://repository.urosario.edu.co/handle/10336/24280
url https://doi.org/10.1007/s12026-016-8816-8
https://repository.urosario.edu.co/handle/10336/24280
identifier_str_mv 0257277X
dc.language.iso.spa.fl_str_mv eng
language eng
dc.relation.citationEndPage.none.fl_str_mv 81
dc.relation.citationIssue.none.fl_str_mv No. 1
dc.relation.citationStartPage.none.fl_str_mv 72
dc.relation.citationTitle.none.fl_str_mv Immunologic Research
dc.relation.citationVolume.none.fl_str_mv Vol. 65
dc.relation.ispartof.spa.fl_str_mv Immunologic Research, ISSN:0257277X, Vol.65, No.1 (2017); pp. 72-81
dc.relation.uri.spa.fl_str_mv https://www.scopus.com/inward/record.uri?eid=2-s2.0-84978870287&doi=10.1007%2fs12026-016-8816-8&partnerID=40&md5=5e3da82270f488d17b93e77e82f2d49d
dc.rights.coar.fl_str_mv http://purl.org/coar/access_right/c_abf2
dc.rights.acceso.spa.fl_str_mv Abierto (Texto Completo)
rights_invalid_str_mv Abierto (Texto Completo)
http://purl.org/coar/access_right/c_abf2
dc.format.mimetype.none.fl_str_mv application/pdf
dc.publisher.spa.fl_str_mv Humana Press Inc.
institution Universidad del Rosario
dc.source.instname.spa.fl_str_mv instname:Universidad del Rosario
dc.source.reponame.spa.fl_str_mv reponame:Repositorio Institucional EdocUR
repository.name.fl_str_mv Repositorio institucional EdocUR
repository.mail.fl_str_mv edocur@urosario.edu.co
_version_ 1814167666448924672